Barclays Increases Nutrien (NYSE:NTR) Price Target to $70.00

Nutrien (NYSE:NTR) had its price objective lifted by research analysts at Barclays from $64.00 to $70.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential downside of 2.51% from the stock’s current price.

Other research analysts have also issued reports about the company. Zacks Research raised Nutrien from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 27th. Royal Bank Of Canada lifted their target price on Nutrien from $70.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, January 20th. Oppenheimer reiterated an “outperform” rating on shares of Nutrien in a report on Tuesday, January 27th. UBS Group raised their price target on shares of Nutrien from $58.00 to $63.00 and gave the company a “neutral” rating in a report on Monday, January 12th. Finally, Scotiabank lifted their price objective on shares of Nutrien from $63.00 to $70.00 and gave the stock a “sector perform” rating in a research report on Monday, February 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $66.69.

Nutrien Trading Up 2.2%

NYSE:NTR opened at $71.80 on Wednesday. Nutrien has a one year low of $45.78 and a one year high of $73.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.89 and a current ratio of 1.41. The firm has a market cap of $34.57 billion, a P/E ratio of 15.41 and a beta of 0.73. The firm has a 50-day simple moving average of $66.06 and a 200-day simple moving average of $60.57.

Nutrien (NYSE:NTR) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.46%. Nutrien’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.31 earnings per share. Equities analysts anticipate that Nutrien will post 3.72 EPS for the current fiscal year.

Institutional Trading of Nutrien

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NTR. Montag A & Associates Inc. increased its holdings in shares of Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares during the period. Sfam LLC purchased a new stake in Nutrien in the fourth quarter valued at approximately $37,000. Root Financial Partners LLC acquired a new position in Nutrien in the 3rd quarter worth approximately $37,000. Huntington National Bank raised its position in Nutrien by 72.6% during the 2nd quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after buying an additional 276 shares during the last quarter. Finally, Eastern Bank lifted its stake in Nutrien by 133.0% during the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Trending Headlines about Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Board raised the quarterly dividend to US$0.55 and approved a new share repurchase program for up to 5% of shares outstanding — a clear cash-return boost that supports the stock. Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program
• Positive Sentiment: Operational results show material improvement year-over-year: Q4 net earnings of ~$580M and adjusted EBITDA of ~$1.28B, with adjusted EPS of $0.83 — indicators of stronger profitability and cash generation in 2025. Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance
• Neutral Sentiment: Barclays raised its price target from $64 to $70 but kept an “equal weight” rating — a modest vote of confidence but not a strong buy signal. Barclays Raises Price Target
• Neutral Sentiment: UBS issued a “hold” on Nutrien, reflecting mixed analyst views and limited near-term upside in some shops. Nutrien (NTR) Gets a Hold from UBS
• Negative Sentiment: Quarterly adjusted EPS and revenue missed consensus (adjusted EPS $0.83 vs. $0.87 est.; revenue $5.12B vs. $5.26B), which pressured the share reaction despite strong year-over-year profitability metrics. Nutrien Q4 Earnings Release and Call
• Negative Sentiment: Some market commentary and data feeds flagged a post-earnings dip and mixed segment-level trends (notably swings in revenue and cash flow metrics), contributing to near-term volatility. Nutrien Stock Falls on Q4 2025 Earnings

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.